Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lyme Arthritis

Infectious Disease Clinics of North America(2022)10.1016/j.idc.2022.03.006Source: DataRank Database

Lyme Arthritis is a research paper published in Infectious Disease Clinics of North America (2022). On theSindex it has a DataRank of 0. It has been cited 52 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access52 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (7)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Allen C. Steere ORCID,Sheila L. Arvikar ORCID

Live enrichment

PubMed:36116835

National Institutes of Health

Grant: R01-AI-101175

National Institutes of Health

Grant: R01-AI-144365

National Institutes of Health

Grant: 5R01AI144365-05

Cellular and humoral immunity in Lyme arthritis

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9533683

publisherhttps://api.elsevier.com/content/article/PII:S0891552022000368?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0891552022000368?httpAccept=text/plain

https://doi.org/10.1016/j.idc.2022.03.006

https://pubmed.ncbi.nlm.nih.gov/36116835

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

Lyme DiseaseArthritisAnti-Inflammatory AgentsHumansAnti-Bacterial Agents

Sustainable Development Goals

SDG 3: 3. Good health